Oncology Imaging Software Market Share

  • Report ID: 5905
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Oncology Imaging Software Industry - Regional Synopsis

North American Market Statistics

The oncology imaging software market in the North America region will have the biggest growth during the forecast period with a revenue share of around 41%. This growth will be noticed owing to the increasing demand for oncology imaging software in this region. Progresses in two-dimensional parallel imaging enhancement, compressed sensing undersampling, and concurrent multislice acquirement recently enabled clinically accessible fourfold to eightfold enhancement of musculoskeletal MRI on 1.5-T and 3.0-T scanners. Thus, the oncology imaging software market in the North American region will have the biggest share of market revenue.

European Market Analysis

The oncology imaging software market in the Europe region will also encounter huge growth during the forecast period and will hold the second position owing to the rising investment in medicated imaging tools by the big key players. For instance, in July 2022, Siemens Healthineers launched its latest mobile X-ray system, Mobilett Impact. The latest system is pocket-friendly and accompanies full digital unification, combining the advantages of mobile X-ray imaging at a patient’s bedside. Multiple groundbreaking technologies have also been denoted by top contenders in the medical imaging business domain to match the increasing requirement for X-ray imaging results for efficient medical diagnosis. Thus, in the European region, the market for oncology imaging software will expand massively.

Oncology Imaging Software Market Shares

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of oncology imaging software is evaluated at USD 4.44 billion.

The oncology imaging software market size was over USD 4.24 billion in 2024 and is poised to exceed USD 8.93 billion by 2037, witnessing over 5.9% CAGR during the forecast period i.e., between 2025-2037. The increasing prevalence of cancer worldwide will drive the market growth.

North America industry is expected to account for largest revenue share of 41% by 2037, owing to increasing demand for oncology imaging software in this region.

The major players in the market include Pfizer Inc., Business PlanningMain Product OfferingsFinancial ExecutionMain Performance IndicatorsStep-Pharma, Novartis A.G., Abbott, Amgen Inc., Biogen, Johnson & Johnson, Merck & Co., Eli Lilly and Company, Hoffmann-La Roche Ltd.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos